A randomized, multicenter, double-blind study of Neoral vs Sandimmune in undergoing liver transplantation;Etude multicentrique prospective randomisee comparative de Sandimmune vs Neoral en transplantation hepatique

Annales de Chirurgie

Volumn 52, Issue 8, 1998, Pages 716-721

  Roy, A ^a   Grant, D R ^a   Kneteman, N M ^a   Tchervenkov, J I ^a   Levy, G A ^a   Tan, A ^a   Hendricks, L ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cyclosporine; Liver transplantation

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; SURVIVAL; TREATMENT OUTCOME; ADULT; AGED; CHEMISTRY; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG MONITORING; FEMALE; FOLLOW UP; GRAFT SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SURVIVAL RATE;

ADMINISTRATION, ORAL; ADULT; AGED; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CYCLOSPORINE; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031768540     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)